Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KBC Asset Management is a prominent European investment firm and a subsidiary of the Belgian KBC Group, specializing in thematic asset management. The firm is widely recognized in the healthcare sector for its specialized investment vehicles, most notably the KBC Eco Fund Life Sciences. This fund targets a global portfolio of companies involved in biotechnology, pharmaceuticals, and medical technology, focusing on innovation and long-term growth. KBC Asset Management employs specialized analysts to evaluate clinical data and market potential across various therapeutic areas, including oncology and rare diseases. While the firm does not develop its own therapeutics, it provides critical capital and financial services to the life sciences industry. Headquartered in Brussels, the company serves both institutional and retail clients, maintaining a strong presence in the European thematic fund market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KBC Funds.